HistoRx Expand its Senior Management Team
News Feb 02, 2006
HistoRx, Inc. has announced the expansion of its senior management team in order to advance the development and commercialization of the Company's first series of molecular diagnostic tests based on the AQUA™ platform.
HistoRx has added three industry leaders with extensive experience in the production and commercialization of protein biomarker discovery and diagnostic products.
The new additions represent a significant increase in the company's effort to advance personalized medicine by stratifying patients and tailoring therapeutic regimes through improved predictive diagnostics.
The new team includes, Donna Marino, vice president of Diagnostics, Lorah Perlee, Ph.D, vice president of Technical Operations, and Robert Tuttle, M.Phil., director of Bioinformatics.
"Building upon the strong uptake of the AQUA™ quantitative pathology platform, this new team will accelerate the commercialization of our pipeline of molecular diagnostic tests with the launch of our first product in early 2008," noted Dr. Robert A. Curtis, president and chief executive officer of HistoRx.
"Additionally in 2006, we plan to significantly expand upon our current pharmaceutical collaborations as well as seek additional partnerships to advance our product and technology development."
The Company has been developing a portfolio of tissue-based molecular tests. The new management will focus on prioritization, development, and commercialization of the tests on the AQUA™ platform.
The AQUA™ platform is designed to represent the first integrated automated fluorescence-based imaging platform to identify and quantitate tissue biomarkers in high throughput tissue microarray format or in whole tissue slices.
The AQUA™ platform measures changes in expression levels of multiple protein biomarkers at the subcellular level while maintaining the spatial relationship between the targets of interest.
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018